NeuRizer Balance Sheet Health
Financial Health criteria checks 3/6
NeuRizer has a total shareholder equity of A$75.0M and total debt of A$244.3K, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are A$127.8M and A$52.8M respectively.
Key information
0.3%
Debt to equity ratio
AU$244.31k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$844.48k |
| Equity | AU$75.04m |
| Total liabilities | AU$52.80m |
| Total assets | AU$127.84m |
Financial Position Analysis
Short Term Liabilities: NRZ's short term assets (A$1.5M) do not cover its short term liabilities (A$52.0M).
Long Term Liabilities: NRZ's short term assets (A$1.5M) exceed its long term liabilities (A$847.0K).
Debt to Equity History and Analysis
Debt Level: NRZ has more cash than its total debt.
Reducing Debt: NRZ's debt to equity ratio has reduced from 14.1% to 0.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NRZ has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NRZ has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8.8% each year